new med for type 2 diabetes, Avandia (rosiglitazone)
There's now a new med for type 2 diabetes, Avandia (rosiglitazone)...from SmithKline Beecham.
It's the first "glitazone" to hit the market in Canada. Rezulin (troglitazone) was approved but never marketed in Canada. Another glitazone, Actos (pioglitazone), is due later this year.
These drugs reduce insulin resistance by stimulating the uptake of glucose into skeletal muscle cells...and decreasing glucose production in the liver.